Literature DB >> 1398481

Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis.

M Parola1, G Leonarduzzi, F Biasi, E Albano, M E Biocca, G Poli, M U Dianzani.   

Abstract

Previous studies have shown that alpha-tocopherol (vitamin E) pretreatment of experimental animals can protect against acute liver necrosis induced by carbon tetrachloride. In this study we investigated whether the increase of vitamin E liver content by dietary supplementation influences chronic liver damage and cirrhosis induced by carbon tetrachloride in the rat. Our data indicate that vitamin E supplementation did not interfere with the growth rate of the animals and increased about threefold the liver's content of the vitamin. Vitamin E supplementation significantly reduced oxidative liver damage, but it was not effective in protecting against development of fatty liver and did not interfere with metabolic activation of carbon tetrachloride. Moreover, vitamin E-fed animals showed incomplete but significant prevention of liver necrosis and cirrhosis induced by carbon tetrachloride. This has been shown by means of histological examination, analysis of serum parameters and biochemical evaluation of collagen content. These results show that an increased liver content of vitamin E can afford a significant degree of protection against carbon tetrachloride-induced chronic liver damage and cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398481     DOI: 10.1002/hep.1840160426

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis.

Authors:  G Montosi; C Garuti; A Iannone; A Pietrangelo
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.

Authors:  Joel Z Stengel; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

3.  Therapeutic Options in Nonalcoholic Fatty Liver Disease.

Authors:  Jeffrey L. Tokar; Carl L. Berg
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

4.  Effects of dietary selenium on the pathological changes and oxidative stress in loach (Paramisgurnus dabryanus).

Authors:  Xiaofeng Hao; Qufei Ling; Fashui Hong
Journal:  Fish Physiol Biochem       Date:  2014-03-16       Impact factor: 2.794

5.  Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis.

Authors:  Mustapha Najimi; Xavier Stéphenne; Christine Sempoux; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.

Authors:  A Pietrangelo; R Gualdi; G Casalgrandi; G Montosi; E Ventura
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride.

Authors:  J Shi; K Aisaki; Y Ikawa; K Wake
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

10.  The multifaceted role of pirfenidone and its novel targets.

Authors:  José Macías-Barragán; Ana Sandoval-Rodríguez; Jose Navarro-Partida; Juan Armendáriz-Borunda
Journal:  Fibrogenesis Tissue Repair       Date:  2010-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.